Clinical Trial Update: Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding pembrolizumab to radiotherapy improves outcomes for newly diagnosed metastatic head and neck squamous cell carcinoma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: UNICANCER | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 3 | Status: RECRUITING